Nano-drug delivery systems integrated with low radiation doses for enhanced therapeutic efficacy in cancer treatment

Table 1 Annual production of scientific publications on glioblastoma nanomedicine from 2009 to 2024, categorized by country¹

Year	China	United States	France	Italy
2009	0	5	0	1
2010	0	16	5	4
2011	8	23	5	6
2012	32	31	11	18
2013	47	88	21	22
2014	51	126	36	36
2015	88	182	62	45
2016	114	254	80	53
2017	208	320	115	74
2018	304	428	132	85
2019	397	508	155	132
2020	519	600	178	176
2021	653	662	218	206
2022	815	724	250	240
2023	991	755	290	284
2024	999	755	293	287

¹The data encompasses the overall document count per annum for China, the United States, France, Italy, and other leading generating nations.

The table depicts the evolution of research volume over time, with values reflecting the increasing influence and emphasis of specific countries in furthering the discipline.